Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

HHV-6 p41 early antigen (9A5D12)
SKU: sc-65447|Size: 200 µg/mL

HHV-6 gp60/110 (2002)
SKU: sc-58156|Size: 100 µg/mL

HHV-6 (2001)
SKU: sc-65463|Size: 100 µg/mL

EBV EBNA1
SKU: ebv-285|Size: 2µg

EBV p18
SKU: ebv-273|Size: 100µg

MOUSE ANTI HERPES VIRUS 6 B VARIANT
SKU: MBS211693-01|Size: 0.1 mg

Mouse Anti Human Herpesvirus 8
SKU: MBS140263-01|Size: 0.005 mg

Human Herpes Virus 7
SKU: FR253|Size: 100 Reactions

Human Herpes Virus (1-5)
SKU: K091B|Size: 100 Reactions

Phospho-RhoA (Ser188) Polyclonal Antibody
SKU: bs-5330R-TR|Size: 20 µL

HHV-6 gp82/105 (2D6) PE
SKU: sc-65448 PE|Size: 200 µg/mL

HHV-6 (20)
SKU: sc-57804|Size: 100 µg/mL

HHV-6 gp116/64/54 (6A5) AC
SKU: sc-65449 AC|Size: 500 µg/mL - 25% ag

HHV-6 gp82/105 (2D6)
SKU: sc-65448|Size: 200 µg/mL

HHV-6 (2001)
SKU: sc-65463|Size: 100 µg/mL

HHV-6 gp116/64/54 (6A5)
SKU: sc-65449|Size: 200 µg/mL

HHV-6 gp82/105 (2D6) HRP
SKU: sc-65448 HRP|Size: 200 µg/mL

HHV-6 gp82/105 (2D6) AC
SKU: sc-65448 AC|Size: 500 µg/mL - 25% ag

Human Herpesvirus 6/7 (HHV-6/7) quantitative
SKU: HHV/GP/025|Size: 25 Tests

Human Herpesvirus 6/7 (HHV-6/7) quantitative
SKU: HHV/GP/100|Size: 100 Tests
